• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1993 Fiscal Year Final Research Report Summary

Pharmacological study on lignins as a class of anti-HIV agents

Research Project

Project/Area Number 04557110
Research Category

Grant-in-Aid for Developmental Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Biological pharmacy
Research InstitutionNagoya City University

Principal Investigator

KAWAZOE Yutaka  Nagoya City University, Fac.of Pharmaceutical Sciences, Professor, 薬学部, 教授 (80106252)

Co-Investigator(Kenkyū-buntansha) KONNO Kunio  Johnan General Hospital, Director (the late), 院長
SUZUKI Hideo  Tsukuba Res.Institute, Toa Gosei Chemical Industry, Director, つくば研究所, 所長 (50013321)
TAKAHASHI Kazuhiko  Nagoya City University, Fac.of Pharmaceutical Sciences, Instructor, 薬学部, 講師 (40117833)
Project Period (FY) 1992 – 1993
KeywordsAIDS treatment / lignins / Anti-HIV / pharmacology
Research Abstract

A class of synthetic lignins (dehydrogenation polymers of p-coumaric acid, ferulic acid, and caffeic acid) inhibited cytopathogenicity of HIV-1 and HIV-2 infection. The polymers inhibited expression of HIV-specific antigen in the intected cells and also inhibited HIV-binding to the cells, but not completely, even at doses that almost completely inhibited the HIV-induced cytopathogenic effect. These results suggest that lignin structure, regardless of whether synthetic or natural, may inhibit HIV replication by an unidentified process, and thus prove to be a new class of anti-HIV agents possibly effective in the treatment of AIDS.
After the dehydrogenation polymer of p-coumaric acid, a synthetic lignin, was intravenously injected into mice, the serum was collected immediately, 15 min, 1 h, 5 h, and 24 h after the injection. The serum thus obtained was added to the assay medium containing MT-4 cells infected with HTLV-IIIB (an HIV-1 strain). Inhibition of the cytopathogenicity of HIV by these serum preparations was assayd by the MTT method. The result revealed that lignins could be a promising class of anti-HIV agents with an unidentified unique mode of action.
For safety assessment on genotoxicity, lignins and related compounds were tested for mutagenicity in Salmonella typhimurium tester strains and none of the compounds examined were proved to be mutagenic. This paper also describes a preliminary result on their antimugtagenic property ; synthetic and some natural lignins suppressed to a remarkable extent mutagenicities of 2-nitrofluorene and 1-nitropyrene, but not those of AF-2 and 4-nitroquinoline 1-oxide. In addition, they inactivated the S9 enzyme resulting in suppression of mutagenicity of Trp-P1, Trp-P2, and Glu-P1.

  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] Hideki Nakashima: "Liginified materials as medicinal resources.V.anti-HIV activity of some synthetic lignins." Chemical and Pharmaceutical Bulletin. 40. 2102-2105 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Naoaki Shimizu: "Lignified materials as medicinal resources.VI.Anti-HIV activity of dehydrogenation polymer of p-coumaric acid,a synthetic lignin,in a quasi-in-vivo assay system as an intermediary step to clinical trials." Biological and Pharmaceutical Bulletin. 16. 434-436 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 麻野間正晴: "医薬品資源としての研究(第7報)Ames法による関連化合物の安全性確認と抗変異原活性" 変異原試験. 2. 239-245 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.Nakashima, T.Murakami, N.Yamamoto, T.Naoe, Y.Kawazoe, K.Konno, H.Sakagami: "Liginified materials as medicinal resources. V.anti-HIV activity of some synthetic lignins." Chem.Pharm.Bull.40. 2102-2105 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] N.Shimizu, T.Naoe, Y.Kawazoe, H.Sakagami, H.Nakashima, T.Murakami, N.Yamamoto: "Liginified materials as medicinal resources. VI.Anti-HIV activity of dehydrogenation polymer of p-coumaric acid, a synthetic lignin, in a quasi-in-vivo assay system as an intermediary step to clinical trials." Biol.Pharm.Bull.16. 434-436 (1993)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1995-03-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi